- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Crystal S. Denlinger Calls for Personalized Care in Cancer Survivorship
As innovations in cancer care transform the disease into a chronic illness, the survivorship population encompasses more than early stage patients but survivors of long term metastatic disease as well, explains Crystal S. Denlinger, MD, Fox Chase Cancer Center in Philadelphia.
As innovations in cancer care transform the disease into a chronic illness, Crystal S. Denlinger, MD, Fox Chase Cancer Center in Philadelphia, says that the survivorship population encompasses more than early stage patients but survivors of long term metastatic disease as well.
Many of the challenges that Dr Denlinger says comes along with cancer survivorship is helping the patient come to terms with the new lifestyle changes that treatment and therapy causes. She adds that patients in different stages of survivorship require different care methods.
“Survivorship care has to be broad enough and as providers, we have to be willing to provide care across those three components of care but with different focuses depending on what stage of disease or what component of survivorship an individual person is living in,”Dr Denlinger says.
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Obesity at Cancer Diagnosis Linked to Worse Survival Outcomes in Pediatric Patients
January 13th 2025Pediatric patients considered obese at cancer diagnosis are linked to significantly worse survival outcomes, especially those with acute lymphoblastic leukemia and central nervous system tumors.
Read More
